Skip to main content

Kara Wegermann

Assistant Professor of Medicine
Medicine, Gastroenterology


My research focuses on genetic predictors of progression in non-alcoholic fatty liver disease (NAFLD) and hepatocellular carcinoma (HCC). I have investigated predictors of clinical progression in non-alcoholic fatty liver disease using the Duke NAFLD clinical database and biorepository. I find the genetic and modifiable risk factors for liver disease fascinating, particularly because of the potential for clinical intervention before cirrhosis or HCC are established.

Current Appointments & Affiliations

Assistant Professor of Medicine · 2024 - Present Medicine, Gastroenterology, Medicine

Education, Training & Certifications

Harvard Medical School · 2014 M.D.